Grant: Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
McGill University
$100,000.00
Transglutaminases and cell-matrix interactions during osteoblast differentiation
FY 2010-11
Summary
Osteoporosis - a skeletal disease characterized by bone loss, bone fragility and increased prevalence of bone fractures - adversely affects the lives of close to 2 million Canadians. Osteoporosis-related fractures result in loss of mobility, increased pain and a dramatically compromised quality of life. The cost of treating osteoporosis-related fractures and immobility is close to 2 billion dollars each year, and it is predicted these numbers will keep increasing as the Canadian population ages. Causes for osteoporosis include links to genetics, nutrition, and medication, and while most prevelant later in life, it can occur at any time during life. Achieving high bone mass at a younger age protects from bone loss later in life. Bones are composed of cells and substance between cells called the extracellular matrix, the latter being mostly collagen that mineralizes (calcifies). Collagen and other matrix proteins produced by bone cells undergoes a stabilization process that is required for proper bone cell function. We have discovered that two transglutaminase enzymes - TG2 and Factor XIIIA - are responsible for this matrix stabilization. Mice lacking these enzymes develop osteoporosis and have low bone mass. In this proposal we plan to further explore how these two enzymes jointly promote bone cell activity. Our specific aims are: 1) to finalize our analysis of mouse bones lacking these two enzymes; 2) to study the role of TG2 in bone cell attachment to bone; 3) to study a newly discovered form of FXIIIA on the surface of bone cells; 4) to study how matrix stabilization occurs at the molecular level resulting in fully functional bone cells. This work in mice will provide important insight into similar human bone formation processes, potentially providing new therapeutic avenues to maintain optimal bone formation activity thoughout life.
Department
Program
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
233079
Name
Kaartinen Mari T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Transglutaminases and cell-matrix interactions during osteoblast differentiation
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Keyworddelim
Biochemistry; Bone; Cell Biology; Cell Culture; Collagen; Extracellular Matrix
Abstract
Osteoporosis - a skeletal disease characterized by bone loss, bone fragility and increased prevalence of bone fractures - adversely affects the lives of close to 2 million Canadians. Osteoporosis-related fractures result in loss of mobility, increased pain and a dramatically compromised quality of life. The cost of treating osteoporosis-related fractures and immobility is close to 2 billion dollars each year, and it is predicted these numbers will keep increasing as the Canadian population ages. Causes for osteoporosis include links to genetics, nutrition, and medication, and while most prevelant later in life, it can occur at any time during life. Achieving high bone mass at a younger age protects from bone loss later in life. Bones are composed of cells and substance between cells called the extracellular matrix, the latter being mostly collagen that mineralizes (calcifies). Collagen and other matrix proteins produced by bone cells undergoes a stabilization process that is required for proper bone cell function. We have discovered that two transglutaminase enzymes - TG2 and Factor XIIIA - are responsible for this matrix stabilization. Mice lacking these enzymes develop osteoporosis and have low bone mass. In this proposal we plan to further explore how these two enzymes jointly promote bone cell activity. Our specific aims are: 1) to finalize our analysis of mouse bones lacking these two enzymes; 2) to study the role of TG2 in bone cell attachment to bone; 3) to study a newly discovered form of FXIIIA on the surface of bone cells; 4) to study how matrix stabilization occurs at the molecular level resulting in fully functional bone cells. This work in mice will provide important insight into similar human bone formation processes, potentially providing new therapeutic avenues to maintain optimal bone formation activity thoughout life.
Competitiondate
201103
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kaartinen, Mari T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~